Product Name

  • Name

    L-Thyroxine

  • EINECS 200-101-1
  • CAS No. 51-48-9
  • Article Data27
  • CAS DataBase
  • Density 2.635 g/cm3
  • Solubility insoluble in water
  • Melting Point 235 °C
  • Formula C15H11I4NO4
  • Boiling Point 576.306 °C at 760 mmHg
  • Molecular Weight 776.875
  • Flash Point 302.339 °C
  • Transport Information
  • Appearance Crystalline Solid
  • Safety 22-24/25-36
  • Risk Codes 40
  • Molecular Structure Molecular Structure of 51-48-9 (L-Thyroxine)
  • Hazard Symbols HarmfulXn
  • Synonyms Thyroxine,L- (8CI);(-)-Thyroxine;3,3',5,5'-Tetraiodo-L-thyronine;Henning;L-T4;L-Thyroxin;Levothyroxine;NSC 36397;T4;T4 (hormone);THX;Tetraiodothyronine;Thyrax;Thyreoideum;Thyroxin;Thyroxinal;Thyroxine;
  • PSA 92.78000
  • LogP 5.25760

Synthetic route

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With sodium hypochlorite; tert-butylamine; sodium iodide In methanol at 20 - 30℃; Reagent/catalyst; Solvent;100%
With iodine; methylamine; potassium iodide In water at 0 - 5℃; for 2h;95%
With iodine; potassium iodide; sodium hydroxide In water at -10 - 10℃; Reagent/catalyst; Temperature;76.7%
With water; iodine; ethylamine; potassium iodide
With ammonia; iodine; potassium iodide
L-thyroxine, sodium salt hexahydrate

L-thyroxine, sodium salt hexahydrate

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With hydrogenchloride In methanol; dimethyl sulfoxide96%
3,5-diiodo-l-tyrosine
300-39-0

3,5-diiodo-l-tyrosine

5,7-diiodo-1-oxaspiro[2.5]octa-4,7-dien-6-one

5,7-diiodo-1-oxaspiro[2.5]octa-4,7-dien-6-one

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 24℃; for 16h; 0.2 M borate buffer, pH 8.0 (add. of 0.1 M NaOH);94%
3,3′-diiodothyronine
70-40-6

3,3′-diiodothyronine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Stage #1: 3,3′-diiodothyronine With methylamine In methanol at 25 - 30℃;
Stage #2: With iodine In methanol at -8 - 0℃;
Stage #3: With potassium dihydrogenphosphate; sodium hydrogensulfite In methanol at 15 - 20℃;
91.2%
3,5-diiodo-l-tyrosine
300-39-0

3,5-diiodo-l-tyrosine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide; butan-1-ol
Multi-step reaction with 4 steps
1.1: sodium hydroxide / water / 1 h
1.2: 2 h / 20 - 40 °C
2.1: diisopropylamine / water; butan-1-ol / 2 h / 20 - 90 °C
2.2: 2 h / 20 - 30 °C
3.1: acetic acid; hydrogen iodide / 5 h / 100 °C
4.1: methylamine / methanol / 25 - 30 °C
4.2: -8 - 0 °C
4.3: 15 - 20 °C
View Scheme
N-acetyl-3,5-diiodo-L-tyrosine
1027-28-7

N-acetyl-3,5-diiodo-L-tyrosine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With air; water at 37℃; Erhitzen des Reaktionsprodukts mit wss. Salzsaeure und Essigsaeure;
3,5-diiodo-l-tyrosine
300-39-0

3,5-diiodo-l-tyrosine

((7R,8S)-8-Hydroxy-5,7-diiodo-6-oxo-1-oxa-spiro[2.5]oct-4-en-2-yl)-oxo-acetic acid

((7R,8S)-8-Hydroxy-5,7-diiodo-6-oxo-1-oxa-spiro[2.5]oct-4-en-2-yl)-oxo-acetic acid

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
at 0℃; for 0.75h; Yield given;
iodoacetamide
27059-94-5

iodoacetamide

3,5-diiodo-thyronine

3,5-diiodo-thyronine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With methanol; triethylamine
1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

3,5-diiodo-l-tyrosine
300-39-0

3,5-diiodo-l-tyrosine

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

butan-1-ol
71-36-3

butan-1-ol

L-thyroxine
51-48-9

L-thyroxine

casein

casein

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Jodierung und anschliessende Hydrolyse;
iodine
7553-56-2

iodine

aqueous sodium hydrogencarbonate solution

aqueous sodium hydrogencarbonate solution

L-thyroxine
51-48-9

L-thyroxine

4-Hydroxymethyl-2,6-diiodo-cyclohexa-2,5-dienone

4-Hydroxymethyl-2,6-diiodo-cyclohexa-2,5-dienone

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 37 percent / NaBiO3 / ethyl acetate; acetic acid; H2O / 4 h
2: 94 percent / dimethylformamide / 16 h / 24 °C / 0.2 M borate buffer, pH 8.0 (add. of 0.1 M NaOH)
View Scheme
3,5-diiodo-DL-thyronine
534-51-0

3,5-diiodo-DL-thyronine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
2: (-)-α-phenethylamine; water
3: hydrobromic acid
4: concentrated ammonia; potassium iodide; iodine
View Scheme
3.5-diiodo-N.O-diacetyl-L-tyrosine
96679-34-4

3.5-diiodo-N.O-diacetyl-L-tyrosine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH solution
2: water; air / 37 °C / Erhitzen des Reaktionsprodukts mit wss. Salzsaeure und Essigsaeure
View Scheme
N-formyl-3,5-diiodo-DL-thyronine
94298-44-9

N-formyl-3,5-diiodo-DL-thyronine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (-)-α-phenethylamine; water
2: hydrobromic acid
3: concentrated ammonia; potassium iodide; iodine
View Scheme
N-formyl-3,5-diiodo-L-thyronine
94298-44-9, 120408-14-2

N-formyl-3,5-diiodo-L-thyronine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrobromic acid
2: concentrated ammonia; potassium iodide; iodine
View Scheme
L-tyrosine
60-18-4

L-tyrosine

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid; iodine monochloride
2: aq. NaOH solution; butanol-(1); aqueous hydrogen peroxide
View Scheme
Multi-step reaction with 8 steps
1: hydrogenchloride / water / 24 h / 20 °C
2: sodium hydrogencarbonate / water; tetrahydrofuran / 24 h / 20 °C
3: N-iodo-succinimide / dichloromethane / 0.67 h / 0 °C
4: N-ethyl-N,N-diisopropylamine; pyridine; copper diacetate / dichloromethane / 48 h / 20 °C / Molecular sieve
5: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.33 h / 0 - 20 °C
6: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
7: lithium hydroxide / water; methanol / 1.5 h / 4 °C
8: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine disodium salt

O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine disodium salt

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With hydrogenchloride In water at 20℃; for 1h; pH=~ 4 - 5;
thyroxine
300-30-1

thyroxine

A

L-thyroxine
51-48-9

L-thyroxine

B

dextrothyroxine
51-49-0

dextrothyroxine

Conditions
ConditionsYield
With chiral stationary phase including isopropyl-functionalized CF6 In methanol; acetic acid; triethylamine; acetonitrile at 20℃; Purification / work up;
methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoate
1431868-09-5

methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoate

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium hydroxide / water; methanol / 1.5 h / 4 °C
2: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoic acid

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoic acid

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 20℃; Inert atmosphere;
L-Tyr-OMe
1080-06-4

L-Tyr-OMe

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: sodium hydrogencarbonate / water; tetrahydrofuran / 24 h / 20 °C
2: N-iodo-succinimide / dichloromethane / 0.67 h / 0 °C
3: N-ethyl-N,N-diisopropylamine; pyridine; copper diacetate / dichloromethane / 48 h / 20 °C / Molecular sieve
4: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.33 h / 0 - 20 °C
5: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
6: lithium hydroxide / water; methanol / 1.5 h / 4 °C
7: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
(S)-N-(tert-butoxycarbonyl)tyrosine methyl ester
4326-36-7

(S)-N-(tert-butoxycarbonyl)tyrosine methyl ester

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: N-iodo-succinimide / dichloromethane / 0.67 h / 0 °C
2: N-ethyl-N,N-diisopropylamine; pyridine; copper diacetate / dichloromethane / 48 h / 20 °C / Molecular sieve
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.33 h / 0 - 20 °C
4: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
5: lithium hydroxide / water; methanol / 1.5 h / 4 °C
6: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-hydroxy-3,5-diiodophenyl)propanoate
128781-80-6

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-hydroxy-3,5-diiodophenyl)propanoate

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: N-ethyl-N,N-diisopropylamine; pyridine; copper diacetate / dichloromethane / 48 h / 20 °C / Molecular sieve
2: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.33 h / 0 - 20 °C
3: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
4: lithium hydroxide / water; methanol / 1.5 h / 4 °C
5: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
C30H43I2NO6Si
1016161-91-3

C30H43I2NO6Si

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.33 h / 0 - 20 °C
2: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
3: lithium hydroxide / water; methanol / 1.5 h / 4 °C
4: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
C21H23I2NO6
1431868-05-1

C21H23I2NO6

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Iodine monochloride; N-butylamine / dichloromethane; N,N-dimethyl-formamide / 0.33 h / 0 °C
2: lithium hydroxide / water; methanol / 1.5 h / 4 °C
3: hydrogenchloride / 1,4-dioxane / 20 °C / Inert atmosphere
View Scheme
3,5-diiodo L-tyrosine copper complex

3,5-diiodo L-tyrosine copper complex

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: diisopropylamine / water; butan-1-ol / 2 h / 20 - 90 °C
1.2: 2 h / 20 - 30 °C
2.1: acetic acid; hydrogen iodide / 5 h / 100 °C
3.1: methylamine / methanol / 25 - 30 °C
3.2: -8 - 0 °C
3.3: 15 - 20 °C
View Scheme
4,4'-dimethoxydiphenyliodonium iodide
6293-71-6

4,4'-dimethoxydiphenyliodonium iodide

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: diisopropylamine / water; butan-1-ol / 2 h / 20 - 90 °C
1.2: 2 h / 20 - 30 °C
2.1: acetic acid; hydrogen iodide / 5 h / 100 °C
3.1: methylamine / methanol / 25 - 30 °C
3.2: -8 - 0 °C
3.3: 15 - 20 °C
View Scheme
2-amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl)propanoic acid
94345-95-6

2-amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl)propanoic acid

L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: acetic acid; hydrogen iodide / 5 h / 100 °C
2.1: methylamine / methanol / 25 - 30 °C
2.2: -8 - 0 °C
2.3: 15 - 20 °C
View Scheme
L-Lactic acid
79-33-4

L-Lactic acid

L-Tartaric acid
87-69-4

L-Tartaric acid

L-thyroxine
51-48-9

L-thyroxine

C4H6O6*C15H11I4NO4*C3H6O3

C4H6O6*C15H11I4NO4*C3H6O3

Conditions
ConditionsYield
at 10 - 20℃; for 168h;99.5%
L-thyroxine
51-48-9

L-thyroxine

L-thyroxine sodium
55-03-8

L-thyroxine sodium

Conditions
ConditionsYield
With sodium carbonate In water Reflux;98%
Stage #1: L-thyroxine With sulfuric acid; ammonia In butan-1-ol at 5 - 65℃; for 1h; pH=8;
Stage #2: With sodium hydroxide In propan-1-ol; butan-1-ol at 25 - 50℃; pH=10;
83%
With sodium carbonate Reflux;79.2%
With sodium carbonate In propan-1-ol; water at 80 - 90℃; for 1h;68%
L-Tartaric acid
87-69-4

L-Tartaric acid

L-thyroxine
51-48-9

L-thyroxine

C4H6O6*C15H11I4NO4

C4H6O6*C15H11I4NO4

Conditions
ConditionsYield
In ethanol for 72h;96%
L-thyroxine
51-48-9

L-thyroxine

Conditions
ConditionsYield
With sodium sulfite In water at 130℃; for 2h; Sealed tube; Microwave irradiation; Green chemistry;92%
L-thyroxine
51-48-9

L-thyroxine

O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine disodium salt

O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine disodium salt

Conditions
ConditionsYield
With sodium hydroxide In propan-1-ol; water at 80 - 90℃;91%
With sodium hydroxide In ethanol for 0.25h; Reflux;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-thyroxine
51-48-9

L-thyroxine

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoic acid

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoic acid

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 2h;90%
In N,N-dimethyl-formamide at 20℃; for 2h;90%
With triethylamine In N,N-dimethyl-formamide at 20℃; for 1h;50%
With sodium carbonate In dimethyl sulfoxide
With hydrogenchloride; sodium hydrogencarbonate In N-methyl-acetamide; methanol; water4.2 g (4.8 mmol, 83%)
L-thyroxine
51-48-9

L-thyroxine

2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

methyl (S)-2-amino-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoate hydrochloride

methyl (S)-2-amino-3-(4-(4-hydroxy-3,5-diaiodophenoxy)-3,5-diaiodophenyl)propanoate hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol; water87%
With hydrogenchloride In methanol; water87%
Boc-Val-ONSu
3392-12-9

Boc-Val-ONSu

L-thyroxine
51-48-9

L-thyroxine

N-(t-butoxycarbonyl)-L-valyl-L-thyroxine

N-(t-butoxycarbonyl)-L-valyl-L-thyroxine

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; water at 20℃; Condensation;85%
L-thyroxine
51-48-9

L-thyroxine

oxalic acid
144-62-7

oxalic acid

C15H11I4NO4*C2H2O4

C15H11I4NO4*C2H2O4

Conditions
ConditionsYield
In ethanol at 10 - 20℃; for 120h;82.5%
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-thyroxine
51-48-9

L-thyroxine

C16H9I4NO5

C16H9I4NO5

Conditions
ConditionsYield
In tetrahydrofuran at 50℃; for 1h;80%
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-thyroxine
51-48-9

L-thyroxine

L-thyroxine-N-carboxyanhydride

L-thyroxine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran at 50℃; for 1h; Inert atmosphere;80%
L-thyroxine
51-48-9

L-thyroxine

α-(N-Trifluoroacetyl)amino-β-[3,5-diiodo-4-(3',5'-diiodo-4'-hydroxyphenoxy)phenyl] propanoic acid
73122-01-7

α-(N-Trifluoroacetyl)amino-β-[3,5-diiodo-4-(3',5'-diiodo-4'-hydroxyphenoxy)phenyl] propanoic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate; trifluoroacetic acid; trifluoroacetic anhydride In water; ethyl acetate70.5%
With sodium hydrogencarbonate; trifluoroacetic acid; trifluoroacetic anhydride In water; ethyl acetate70.5%
L-thyroxine
51-48-9

L-thyroxine

ethyl iodide
75-03-6

ethyl iodide

2-(ethylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
1021496-83-2

2-(ethylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 2h;62%
In N,N-dimethyl-formamide at 20℃; for 2h;62%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

L-thyroxine
51-48-9

L-thyroxine

2-(butyrylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
806620-06-4

2-(butyrylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;50%
Stage #1: L-thyroxine With triethylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: butanoic acid anhydride In N,N-dimethyl-formamide at 20℃;
45%
Stage #1: L-thyroxine With triethylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: butanoic acid anhydride In N,N-dimethyl-formamide at 20℃; for 0.75h;
45%
L-thyroxine
51-48-9

L-thyroxine

acetic anhydride
108-24-7

acetic anhydride

2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
26041-53-2

2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid

Conditions
ConditionsYield
Stage #1: L-thyroxine With triethylamine In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: acetic anhydride In N,N-dimethyl-formamide at 20℃;
50%
With pyridine at 0 - 23℃; for 12h; Inert atmosphere;
L-thyroxine
51-48-9

L-thyroxine

ethyl iodide
75-03-6

ethyl iodide

ethyl 2-(ethylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
1083039-06-8

ethyl 2-(ethylamino)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

Conditions
ConditionsYield
Stage #1: L-thyroxine With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: ethyl iodide In N,N-dimethyl-formamide at 20℃; for 1h;
50%
Stage #1: L-thyroxine With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: ethyl iodide In N,N-dimethyl-formamide at 20℃;
10%
L-thyroxine
51-48-9

L-thyroxine

biotinamidocaproate N-hydroxysuccinimide ester
89889-52-1

biotinamidocaproate N-hydroxysuccinimide ester

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; dimethyl sulfoxide at 20℃; Cooling with ice;42%
L-thyroxine
51-48-9

L-thyroxine

L-thyroxine sulfate

L-thyroxine sulfate

Conditions
ConditionsYield
With chlorosulfonic acid; trifluoroacetic acid at 0℃; for 0.166667h;40%
L-thyroxine
51-48-9

L-thyroxine

methyl iodide
74-88-4

methyl iodide

potassium 3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-2-(methylamino)propanoate dihydrate
1234572-93-0

potassium 3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-2-(methylamino)propanoate dihydrate

Conditions
ConditionsYield
Stage #1: L-thyroxine; methyl iodide In N,N-dimethyl-formamide at 20℃; for 2h;
Stage #2: With potassium carbonate In N,N-dimethyl-formamide
24%
Stage #1: L-thyroxine; methyl iodide With triiodothyronine In N,N-dimethyl-formamide at 20℃; for 2h;
Stage #2: With potassium carbonate In water; N,N-dimethyl-formamide
24%
L-thyroxine
51-48-9

L-thyroxine

O-[3,5-diiodo-4-(sulfooxy)phenyl]-3,5-diiodo-L-tyrosine sodium salt

O-[3,5-diiodo-4-(sulfooxy)phenyl]-3,5-diiodo-L-tyrosine sodium salt

Conditions
ConditionsYield
Stage #1: L-thyroxine With chlorosulfonic acid In N,N-dimethyl acetamide at 0 - 20℃; for 5h; Inert atmosphere;
Stage #2: With sodium hydrogencarbonate; sodium carbonate In N,N-dimethyl acetamide; water for 1.5h;
18%
L-thyroxine
51-48-9

L-thyroxine

O-(4-hydroxyphenyl)-3,5-diiodo-L-tyrosine
1596-67-4

O-(4-hydroxyphenyl)-3,5-diiodo-L-tyrosine

Conditions
ConditionsYield
With potassium hydroxide; palladium Hydrogenation;
With sodium tetrahydroborate; C10H8STe; D,L-dithiothreitol In aq. phosphate buffer at 37℃; for 0.5h; pH=7.5; Reagent/catalyst;
L-thyroxine
51-48-9

L-thyroxine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

N-chloroacetyl-3,5,3',5'-tetraiodo-L-thyronine
97738-15-3

N-chloroacetyl-3,5,3',5'-tetraiodo-L-thyronine

Conditions
ConditionsYield
With ethyl acetate
L-thyroxine
51-48-9

L-thyroxine

dimethyl sulfate
77-78-1

dimethyl sulfate

4-(3,5-diiodo-4-methoxy-phenoxy)-3,5-diiodo-trans-cinnamic acid

4-(3,5-diiodo-4-methoxy-phenoxy)-3,5-diiodo-trans-cinnamic acid

Conditions
ConditionsYield
With sodium hydroxide

L-Thyroxine Specification

The Levothyroxine, with the CAS registry number 51-48-9, is also known as L-thyroxine. It belongs to the product categories of Amino Acids; Organics; Heterocyclic Compounds; Amino Acids & Derivatives; Intermediates & Fine Chemicals; Pharmaceuticals; Isotope Labeled Compounds. Its EINECS registry number is 200-101-1. This chemical's molecular formula is C15H11I4NO4 and molecular weight is 776.87002. Its IUPAC name is called (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid. This chemical's classification codes are Hormone; Human Data; Mutation data; Reproductive Effect. 

Physical properties of Levothyroxine: (1)ACD/LogP: 4.72; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 2.206; (4)ACD/LogD (pH 7.4): 1.678; (5)ACD/BCF (pH 5.5): 6.982; (6)ACD/BCF (pH 7.4): 2.069; (7)ACD/KOC (pH 5.5): 27.027; (8)ACD/KOC (pH 7.4): 8.01; (9)#H bond acceptors: 5; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 7; (12)Index of Refraction: 1.795; (13)Molar Refractivity: 125.446 cm3; (14)Molar Volume: 294.745 cm3; (15)Surface Tension: 79.617 dyne/cm; (16)Density: 2.636 g/cm3; (17)Flash Point: 302.339 °C; (18)Enthalpy of Vaporization: 90.781 kJ/mol; (19)Boiling Point: 576.306 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.

Preparation: this chemical can be extracted from animal thyroid, but also can use 5-bis iodine-L-tyrosine as raw material.

Levothyroxine can be used as a hormone replacement for patients with thyroid problems. This medicine is a hormone replacement usually given to patients with hypothyroidism. Levothyroxine is also frequently used to treat goiter because it usually lowers the levels of thyroid-stimulating hormone, a hormone that is considered goitrogenic. This chemical can be used in veterinary. The dosage for dogs with hypothyroidism is usually a twice daily dose of between 10-40 μg per kg of body weight.

When you are using this chemical, please be cautious about it as the following:
This chemical may cause damage to health. There is limited evidence of a carcinogenic effect. You should not breathe its dust. What's more, you must avoid contacting it with skin and eyes. Whenever you will contact it, please wear suitable protective clothing.

You can still convert the following datas into molecular structure:
(1)Canonical SMILES: C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
(2)Isomeric SMILES: C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N
(3)InChI: InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
(4)InChIKey: XUIIKFGFIJCVMT-LBPRGKRZSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 328ug/kg (0.328mg/kg) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
Pediatrics. Vol. 73, Pg. 313, 1984.
man TDLo oral 63ug/kg (0.063mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 517, 1983.
man TDLo oral 10286ug/kg (10.286mg/kg) BEHAVIORAL: EXCITEMENT

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

GASTROINTESTINAL: NAUSEA OR VOMITING
Veterinary and Human Toxicology. Vol. 41, Pg. 323, 1999.
women TDLo oral 400ug/kg/2D-I (0.4mg/kg) BEHAVIORAL: COMA

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)
Intensive Care Medicine. Vol. 13, Pg. 33, 1987.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View